361 related articles for article (PubMed ID: 22102982)
41. Redox processes in neurodegenerative disease involving reactive oxygen species.
Kovacic P; Somanathan R
Curr Neuropharmacol; 2012 Dec; 10(4):289-302. PubMed ID: 23730253
[TBL] [Abstract][Full Text] [Related]
42. Zinc, Carnosine, and Neurodegenerative Diseases.
Kawahara M; Tanaka KI; Kato-Negishi M
Nutrients; 2018 Jan; 10(2):. PubMed ID: 29382141
[TBL] [Abstract][Full Text] [Related]
43. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
Giampietro R; Spinelli F; Contino M; Colabufo NA
Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
[TBL] [Abstract][Full Text] [Related]
44. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases.
Arnold SE; Toledo JB; Appleby DH; Xie SX; Wang LS; Baek Y; Wolk DA; Lee EB; Miller BL; Lee VM; Trojanowski JQ
J Comp Neurol; 2013 Dec; 521(18):4339-55. PubMed ID: 23881776
[TBL] [Abstract][Full Text] [Related]
45. The role of zinc, copper, manganese and iron in neurodegenerative diseases.
Mezzaroba L; Alfieri DF; Colado Simão AN; Vissoci Reiche EM
Neurotoxicology; 2019 Sep; 74():230-241. PubMed ID: 31377220
[TBL] [Abstract][Full Text] [Related]
46. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective.
Su LD; Wang N; Han J; Shen Y
Neuroscientist; 2022 Oct; 28(5):453-468. PubMed ID: 34088252
[TBL] [Abstract][Full Text] [Related]
47. Metals and Neurodegeneration.
Chen P; Miah MR; Aschner M
F1000Res; 2016; 5():. PubMed ID: 27006759
[TBL] [Abstract][Full Text] [Related]
48. Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases.
Hague T; Andrews PL; Barker J; Naughton DP
Behav Pharmacol; 2006 Sep; 17(5-6):425-30. PubMed ID: 16940763
[TBL] [Abstract][Full Text] [Related]
49. Inflammation and Parkinson's disease.
Wersinger C; Sidhu A
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):221-42. PubMed ID: 14561187
[TBL] [Abstract][Full Text] [Related]
50. Prophylactic zinc supplementation modulates hippocampal ionic zinc and partially remediates neurological recovery following repetitive mild head injury in mice.
Neely CLC; Barkey RE; Hernandez CM; Flinn JM
Behav Brain Res; 2022 Jul; 430():113918. PubMed ID: 35533893
[TBL] [Abstract][Full Text] [Related]
51. An update on pharmacological approaches to neurodegenerative diseases.
Scatena R; Martorana GE; Bottoni P; Botta G; Pastore P; Giardina B
Expert Opin Investig Drugs; 2007 Jan; 16(1):59-72. PubMed ID: 17155854
[TBL] [Abstract][Full Text] [Related]
52. Metal ions, Alzheimer's disease and chelation therapy.
Budimir A
Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
[TBL] [Abstract][Full Text] [Related]
53. [Brain zinc dyshomeostasis and glial cells in ischemic stroke].
Higashi Y; Aratake T; Shimizu S; Shimizu T; Saito M
Nihon Yakurigaku Zasshi; 2019; 154(3):138-142. PubMed ID: 31527364
[TBL] [Abstract][Full Text] [Related]
54. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
Sivagurunathan N; Ambatt ATS; Calivarathan L
Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
[TBL] [Abstract][Full Text] [Related]
55. Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases.
Novellino F; Saccà V; Donato A; Zaffino P; Spadea MF; Vismara M; Arcidiacono B; Malara N; Presta I; Donato G
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046139
[TBL] [Abstract][Full Text] [Related]
56. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
57. Increased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Dang TN; Lim NK; Grubman A; Li QX; Volitakis I; White AR; Crouch PJ
Front Aging Neurosci; 2014; 6():15. PubMed ID: 24575040
[TBL] [Abstract][Full Text] [Related]
58. An attempt to elucidate the role of iron and zinc ions in development of Alzheimer's and Parkinson's diseases.
Wojtunik-Kulesza K; Oniszczuk A; Waksmundzka-Hajnos M
Biomed Pharmacother; 2019 Mar; 111():1277-1289. PubMed ID: 30841441
[TBL] [Abstract][Full Text] [Related]
59. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
60. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
